The Protein Tyrosine Phosphatase TCPTP Suppresses the Tumorigenicity of Glioblastoma Cells Expressing a Mutant Epidermal Growth Factor Receptor-Reference-Cited by-同舟云学术

The Protein Tyrosine Phosphatase TCPTP Suppresses the Tumorigenicity of Glioblastoma Cells Expressing a Mutant Epidermal Growth Factor Receptor

Published:2001-12 Issue:49 Volume:276 Page:46313-46318
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Klingler-Hoffmann Manuela,Fodero-Tavoletti Michelle T.,Mishima Kazuhiko,Narita Yoshitaka,Cavenee Webster K.,Furnari Frank B.,Huang H.-J. Su,Tiganis Tony

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference31 articles.

1. Gliomagenesis: genetic alterations and mouse models

2. Malignant glioma: genetics and biology of a grave matter

3. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of protein phosphorylation by PTPN2 and its small-molecule inhibitors/degraders as a potential disease treatment strategy;European Journal of Medicinal Chemistry;2024-11

2. Protein tyrosine phosphatase nonreceptor type 2 exerts antimetastatic functions in pancreatic ductal adenocarcinoma;Molecular Carcinogenesis;2023-05-19

3. Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancers;Heliyon;2023-01

4. PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review;International Journal of Molecular Sciences;2022-09-02

5. Comprehensive Pan-Cancer Analysis Reveals PTPN2 as an Immune Checkpoint and Prognostic Biomarker;SSRN Electronic Journal;2022